SEARCH

SEARCH BY CITATION

References

  • Alexanian, R., Dimopoulos, M.A., Delasalle, K. & Barlogie, B. (1992) Primary dexamethasone treatment of multiple myeloma. Blood, 80, 887890.
  • Alexanian, R., Dimopoulos, M.A., Hester, J., Delasalle, K. & Champlin, R. (1994) Early myeloablative therapy for multiple myeloma. Blood, 84, 42784282.
  • Alexanian, R., Weber, D., Giralt, S., Dimopoulos, M., Delasalle, K., Smith, T. & Champlin, R. (2001) Impact of complete remission with intensive therapy in patients with responsive multiple myeloma. Bone Marrow Transplantation, 27, 10371043.
  • Anderson, J.R., Cain, K.C. & Gelber, R.D. (1983) Analysis of survival by tumor response. Journal of Clinical Oncology, 1, 710719.
  • Dimopoulos, M.A., Zervas, K., Kouvatseas, G., Galani, E., Grigoraki, V., Kiamouris, C., Vervessou, E., Samantas, E., Papadimitriou, C., Economou, O., Gika, D., Panayiotidis, P., Christakis, I. & Anagnostopoulos, N. (2001) Thalidomide and dexamethasone combination for refractory multiple myeloma. Annals of Oncology, 12, 991995.
  • Hideshima, T., Chauhan, D., Shima, Y., Raje, N., Davies, F., Tai, Y., Treon, S., Lin, B., Schlossman, R., Richardson, P., Muller, G., Stirling, D. & Anderson, K. (2000) Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy. Blood, 96, 29432950.
  • Kaplan, E. & Meier, P. (1958) Non-parametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457481.
  • Peto, R., Pike, M., Armitage, N., Breslow, N., Cox, D., Howard, S., Mantel, N., McPherson, K., Peto, J. & Smith, P. (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. British Journal of Cancer, 35, 139.
  • Rajkumar, S.V., Fonseca, R., Dispenzieri, A., Lacy, M., Lust, J., Witzig, T., Kyle, R., Gertz, M. & Greipp, P. (2000) Thalidomide in the treatment of relapsed multiple myeloma. Mayo Clinic Procedings, 75, 897901.
  • Singhal, S., Mehta, K., Desikan, R., Ayers, D., Roberson, P., Eddlemon, P., Munshi, N., Anaissie, E., Wilson, C., Dhodapkar, M., Zeldis, J. & Barlogie, B. (1999) Antitumor activity of thalidomide in refractory multiple myeloma. New England Journal of Medicine, 341, 15651571.
  • Weber, D., Delasalle, K., Giralt, S. & Alexanian, R. (1999) Thalidomide alone or with dexamethasone for multiple myeloma. Blood, 94, 604a.
  • Weber, D., Walker, P., Oholendt, M., Rankin, K., Gavino, M., Delasalle, K., & Alexanian, R. (2002) Correlation of thrombotic/embolic events with features of hypercoagulability in previously untreated patients before and after treatment with thalidomide or thalidomide–dexamethasone. Blood, 100, 180a.